FORM 10-QSB
                                
               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D. C. 20549
                                
(Mark One)
   [X]QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE
       SECURITIES EXCHANGE ACT OF 1934
                                
            For the Quarter Ended September 30, 1998
                               OR
   [   ]    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)  OF
   THE
       SECURITIES EXCHANGE ACT OF 1934
                                
                 COMMISSION FILE NUMBER 0-14724
                                
                        ARNOX CORPORATION
       (Exact name of Issuer as specified in its charter)
           Delaware                                  59-3453156
(other jurisdiction of                               (I.R.S. Employer
incorporation or organization)                       Identification No.)
                                
                     1612 N. Osceola Avenue
                    Clearwater, Florida 33755
                 (Address of principal offices)
                         (727) 443-3434
        (Issuer's telephone number, including area code)
                                
    Indicate  by check mark whether the Issuer (1) has filed  all
reports  required  to be filed by Section 13 or  15  (d)  of  the
Securities  Exchange Act of 1934 during the preceding  12  months
(or  for such shorter period that the Issuer was required to file
such   reports)  and  (2)  has  been  subject  to   such   filing
requirements for the past 90 days.
                                              Yes  [X]  No  [   ]

    State  the  number  of  shares outstanding  of  each  of  the
issuer's  classes  of common stock, as of the latest  practicable
dates.
                                
     Title of Each Class         Outstanding at September 30, 1998
                                
Common Stock, $0.001 Par Value            3,439,247 Shares
                                 subject to 11.4642 reverse split,
                               approved by stockholders July 7, 1997

                        TABLE OF CONTENTS
                                
                                
                                

PART I FINANCIAL INFORMATION                                 PAGE
ITEM 1 Financial Statements
       Consolidated Balance Sheets as of September 30, 1998
        and September 30, 1997                                  3
       Consolidated Statements of Income for the Nine Month
        Periods Ended September 30, 1998 and September 30, 1997.
                                                                 4
       Consolidated Statements of Cash Flow for the Nine Month
        Periods Ended September 30, 1998 and September 30, 1997. 5
       Notes to Financial Statements                             6
ITEM 2 Management's Discussion and Analysis of
       Financial Condition and Results of Operations             7

PART II   OTHER INFORMATION                                      9
       SIGNATURES                                                9
                        ARNOX CORPORATION
                    (a Dormant State Company)
                   Consolidated Balance Sheet
            September 30, 1998 and September 30, 1997
                           (unaudited)
                                
                                09/30/98   09/30/97
 Assets


Organization Cost             $    0      $    0

 Total Assets                      0           0

Liabilities and Shareholder's Equity

Stockholders' Equity

Common Stock par value at $.001 per share
10,000,000 shares authorized,
 3,439,247.00 shares issued and outstanding      0  0
Net Income/Loss                (26,451)     (12,794)
Additional Paid in Capital      26,451       12,794
Retained  Earnings (Deficit)       (0)         (0)
                                ______
_______


Total Shareholders' Equity         0          0
                                     ______
_______

Total Liabilities and Shareholders Equity     $      0  $  0
                              =========   ========






         See accompanying notes to financial statements

                        ARNOX CORPORATION
                    (a Dormant State Company)
             Consolidated  Statements of Operations
 for the nine month ending September 30, 1998 and September 30,
                              1997
                           (unaudited)


                                1998          1997*
                              09/30/98       09/30/97
                              _______        ________

Revenues                      $    0         $   0

Expenses
Administrative Expenses       $8,669         $5,979
Filing Fees                   $    0         $   0

Net Income/Loss for the year  $(8,669)       $ (5,979)
                              =========      ========


         See accompanying notes to financial statements
                                
                                

                        ARNOX CORPORATION
                    (a Dormant State Company)
             Consolidated Statements of  Cash Flows
       for nine months ended September 30, 1998 and  1997
                           (unaudited)
                                
                                
                              For Nine Months Ended
                                09/30/98            09/30/97

Cash Flows from Operating Activities
 Net Income                       $ (8,669)             (5,979)

Net Cash Provided (used) /
By Operating Activities                   0                 0


Expenses Paid by Capston                8,669            5,979

Net Increase (Decrease) in Cash             0                0
Cash at Beginning of Period                 0                0

Cash at End of Period               $       0           $    0
                                          =====              ==
                                
                                

                                
                                
                                
                                
                                
                                
                                
                                
                                
                                
                                
         See accompanying notes to financial statements
                                
                        ARNOX CORPORATION
                    (A Dormant State Company)
                                
                       September 30, 1998

Note 1. HISTORY OF THE COMPANY

ARNOX   Corporation, (A Dormant State Company), was  incorporated
on  October  17, 1983, under the laws of the State  of  Delaware.
The  Company conducted an initial public offering of  its  Common
Stock  in October, 1985 and in connection with an application  to
list  its  Common  Stock on the NASDAQ system, the  Company  also
registered  its  Common Stock pursuant to Section  12(g)  of  the
Securities  Exchange  Act of 1934.  The  Company's  Common  Stock
remained listed on the NASDAQ system until April 25, 1989.

On   September 11, 1989, the  Company filed a voluntary  petition
under  Chapter 11 of the Bankruptcy ACT (Case  No.  89-97155)  in
the  U.S.  Bankruptcy Court for the District of New Jersey.    On
December  18,  1989,  the Company's case  under  Chapter  11  was
voluntarily  converted  into  a  case  under  Chapter  7  of  the
Bankruptcy Act.  As a result of the voluntary conversion  of  the
Company's  bankruptcy  case,  all  assets  of  the  Company  were
transferred  to the Trustee in Bankruptcy on the conversion  date
and the Company ceased all operations.  Subsequently, the Trustee
in Bankruptcy effected an orderly liquidation of corporate assets
and  used the proceeds to repay the Company's creditors.  On July
12,  1994  the  Company's case under Chapter 7 was closed  by  an
order  of the Court and the Trustee in Bankruptcy was discharged.
As  a  result  of  the  Bankruptcy, the Company  has  no  assets,
liabilities, management or ongoing operations and has not engaged
in any business activities since December 18, 1989.

Note 2. RESTORATION OF CORPORATE STATUS

On  June  10, 1996, acting in its capacity as the holder  of  884
shares (0.026%)  of the Company's common stock, and without first
receiving  the consent, approval or authorization  of  any  other
person  associated  with  the Company,  Capston  Network  Company
effected  a  renewal, revival and restoration  of  the  Company's
certificate  of  incorporation pursurant to Section  312  of  the
General Corporation Law of Delaware.  Thereafter, Capston filed a
10-K  for  the years ending December 31, 1989-1995, and  a  Proxy
Statement seeking approval and ratification of its actions, along
with  authorization  to  seek  a  suitable  business  combination
transaction.  This proxy statement was ultimately distributed  to
the   Company's  stockholders  and  the  proposals  therein  were
approved by the holders of a majority of the Company's issued and
outstanding shares.

Under  the  terms  of the original Proxy Statement,  Capston  was
authorized to seek a suitable business combination transaction on
behalf  of  the Company and to submit the terms of  any  proposed
business  combination  transaction to the Company's  stockholders
for their approval.  Capston did not receive and was not entitled
to receive any equity interest in the Company as a result of it's
actions  prior  to  the  date of the Proxy Statement.   Moreover,
Capston  was  not  entitled  to reimbursement  for  any  expenses
incurred  by  it  on behalf of the Company except to  the  extent
that the terms of a business combination transaction provided for
the reimbursement of such expenses. However, because Sally Fonner
is  both  the  President  of  ARNOX  and   Capston,  prior  Staff
Accounting  Bulletins require under generally accepted accounting
the  treatment of debiting the expenses with corresponding credit
to  paid-in capital.  Future expenses of Capston or others   will
be  treated this way. These expenses are actual cash expenditures
and  do  not  reflect any costs associated with the operation  of
Capston nor any personnel time or cost.

Note 3. FUTURE EXPENSES

Capston  will continue to extend administrative expenses to  keep
ARNOX  current  with  its  reporting  requirements,  keeping  the
Corporation in good standing, any required proxy solicitation  or
acquisition efforts.  These amounts should not exceed $50,000  in
out-of-pockets costs.  In addition, as approved, and as a  result
of  a  suitable acquisition, additional fees paid for by issuance
of  equity position  would be for: (i) Capston of 300,000 shares,
(ii)up  to 11,500,000 shares for  an acquisition(s) and (iii)  up
to 5% of the acquisition for a finder's fee .


Item 2. Management Discussion and Analysis of Financial Condition
and Results of Operations.


Financial Condition

    As  a  result  of  its 1989 Bankruptcy, the  Company  has  no
assets, liabilities, or ongoing operations and has not engaged in
any business activities since September 1989. The Company had  no
operations  during  the  year ended  December  31,  1996  and  no
material  assets  or  liabilities as of December  31,  1996.  The
reported  loss  from  operations in  1996  resulted  solely  from
expenses  incurred  by  Capston  on  behalf  of  the  Company  in
connection  with  the  restoration  of  the  Company's  corporate
charter  and  the  preparation  and  filing  of  certain  reports
required  under the Securities Exchange Act of 1934.   Management
received  stockholder  approval of a  Revised  Plan  whereby  the
Company  was restructured as a "public shell" for the purpose  of
effecting  a  business combination transaction  with  a  suitable
privately-held  company  that  has  both  business  history   and
operating  assets,  although  there  can  be  no  assurance  that
management will be successful in its effforts to negotiate such a
transaction.

Results of Operations

    We  are  still seeking a suitble acquisition candidate.   The
candidates  to date lack the efficient resources to be  a  public
company  or have not had an audit or did not have the ability  to
great a prescense within the market place.

Plan of Operation.

    The Company has not engaged in any material operations or had
any  revenues  from  operations during the two preceeding  years.
The Company's plan of operation for the next twelve months is  to
continue  to seek the acquisition of assets, property or business
that  may benefit the Company and its stockholders.  Because  the
Company  has no resources, management anticipates that to achieve
any  such  acquisition, the Company will  be  required  to  issue
shares  of  its common stock as the sole consideration  for  such
acquisition.

    During the next twelve months, the Company's only foreseeable
cash  requirements will relate to maintaining the Company in good
standing or the payment of expenses associated with reviewing  or
investigating   any   potential  business  venture,   which   are
anticipated  to be advanced by Capston as loans to  the  Company.
Because the Company has not identified any such venture as of the
date  of this Registration Statement, it is impossible to predict
the  amount  of any such loans.  However, any loans from  Capston
will  be on terms no less favorable to the Company than would  be
available   from   a  commercial  lender  in  an   arm's   length
transaction.

    Capston  will continue to extend administrative  expenses  to
keep  ARNOX current with its reporting requirements, keeping  the
Corporation in good standing, any required proxy solicitation  or
acquistion  efforts. Management anticipates  that  Capston,  will
advance   minor   administrative  expenses  up  to  approximately
$5,000.*These amounts should not exceed $50,000 in out-of-pockets
costs.    Additional costs associated with a business combination
paid  for  by  issuance of equity position   would  be  for:  (i)
Capston  of 300,000 shares, (ii)up to 11,500,000 shares  for   an
acquisition(s)  and  (iii) up to 5%  of  the  acquisition  for  a
finder's fee. In the event that additional funding is required in
order  to  keep the Company in good standing and/or to review  or
investigate  any potential merger or acquisition  candidate,  the
Company  may  attempt  to raise such funding  through  a  private
placement of its common stock to accredited investors.

    At the present time, management has no plans to offer or sell
any  securities  of the Company.  However, at such  time  as  the
Company  may decide to engage in such activities, management  may
use  any  legal means of conducting such offer or sale, including
registration  with the appropriate federal and  state  regulatory
agencies and any registration exemptions that may be available to
the Company under applicable federal and state laws.

    Because  the Company is not currently making any offering  of
its  securities, and does not anticipate making any such offering
in  the foreseeable future, management does not believe that Rule
419  promulgated by the Securities and Exchange Commission  under
the  Securities Act of 1933, as amended, concerning offerings  by
blank check companies, will have any effect on the Company or any
activities in which it may engage in the foreseeable future.


PART II - OTHER INFORMATION

ITEM 1.LEGAL PROCEEDINGS

       NONE

ITEM 2.CHANGES IN SECURITIES
       AS OF SEPTEMBER  25, 1997, LUMIERE SECURITIES RECEIVED
       CLEARANCE TO MAKE A MARKET IN ARNOX UNDER THE TRADING
       SYMBOL ARXC.

ITEM 3.DEFAULTS ON SENIOR SECURITIES
       NONE

ITEM 4.SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
      NONE

ITEM 5.OTHER INFORMATION
       NONE

ITEM 6.EXHIBITS AND REPORTS ON FORM 8-K
       A. Exhibits   None
       B. Reports on Form 8-K      None
       
                                
                                
                           SIGNATURES
    Pursuant  to the requirements of the Securities and  Exchange
Act  of  1934, the Registrant has duly caused this report  to  be
signed   on   its  behalf  by  the  undersigned  thereunto   duly
authorized.

                                   ARNOX Corporation
                                   
                                      /S/

                                   Sally A. Fonner
                                   Chief Executive Officer
                                   Dated: September 30, 1998
                                   
                                      /S/

                                   Sally A. Fonner
                                   Chief Financial Officer
                                   Dated: September 30, 1998